Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

A Prospective Randomized, Multi-center Study to Assess the Safety and Efficacy of Mucosta (Rebamipide), in Combination With Omeprazole as Adjuvant Therapy in Gastric Ulcer Patients

A Prospective Randomized, Multi-center study to assess the Safety and Efficacy of Mucosta (Rebamipide), in combination with Omeprazole as adjuvant therapy in Gastric Ulcer Patients.

Inclusion Criteria:

• Patients with dyspepsia or epigastric pain and endoscopically proven gastric and duodenal ulcers
• Required laboratory parameters and time limits (screening blood tests will be taken including hemoglobin, white blood cell count, random glucose, potassium, sodium, chlorine, creatinine, AST, ALT, bilirubin, and alkaline phosphatase)
• Age > 18 years
• A statement that all patients must have signed an informed consent form prior to registration in study

Exclusion Criteria:

• Patients who had undergone surgery for ulcers
• History of hypersensitivity to drugs to be used in the study
• Women who are pregnant or lactating or intended to get pregnant during the study period